Ori Spotlight.
The Ori Spotlight podcast covers the latest in cell and gene therapy. Ori CEO Jason C. Foster is joined by leaders from across the industry, to learn more about how we can break down the barriers and seize the opportunities to ensure every patient has access to life-changing treatments.
All Episodes
Ori Spotlight #38 – Anshul Mangal, Project Farma
Unlocking scale, automation, digitalization and standardization in CGT. …
Read more
Ori Spotlight #37 – Omkar Kawalekar, Deloitte
Technology will unlock scalability and patient access. …
Read more
Ori Spotlight #36 – Joe DePinto, McKesson
Bridging growth and accessibility within CGTs. …
Read more
Ori Spotlight #35 – Matthew Hewitt, Charles River Laboratories
Scalability is a collective problem. …
Read more
Ori Spotlight #34 – Adam Siebert and Jeff Holder, LEK Consulting
Early investment in manufacturing is critical for CGT accessibility. …
Read more
Ori Spotlight #33 – Jim Faulkner, JBD BioConsulting
Unaffordable therapy success is worse than failure. …
Read more
Ori Spotlight #32 – Sanjay Srivastava, Accenture’s CGT Practice
Are CGTs developing into a commercial dead-end? …
Read more
Ori Spotlight #31 – Tim Hunt, Alliance for Regenerative Medicine (ARM)
Leading CGT with education and community. …
Read more
Ori Spotlight #30 – Vered Caplan, Orgenesis
Why yesterday's thinking is not going to solve today's problems. …
Read more
Ori Spotlight #29 – Daniel Gibson, Anthony Nolan
Improving patient access to cell therapies. …
Read more
Ori Spotlight #28 – Dr. Betty Woo, ThermoFisher
Why it's important to take calculated risks early in your …
Read more
Ori Spotlight #27 – John Lee, Breakthrough Medicines
"Cellicon Valley" accelerates development and manufacturing of innovative CGTs. …
Read more